(Q34395012)

1 August 2017

1 reference

title

New and experimental therapies for pulmonary hypertension (English)

1 reference

1 August 2017

Channick RN

1

1 reference

PubMed ID

11590847

1 August 2017

Rubin LJ

series ordinal

2

1 reference

1 August 2017

1 September 2001

1 reference

Clinics in Chest Medicine

1 August 2017

1 reference

1 August 2017

22

1 reference

1 August 2017

539-545

1 reference

1 August 2017

3

1 reference

Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Vascular remodeling and ET-1 expression in rat strains with different responses to chronic hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

The endothelin-A-receptor antagonist PD 180988 (CI-1034) selectively reverses the pulmonary vasoconstrictor response to hypoxia in the lamb

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

The ET(A)-Receptor Antagonist LU 135252 Prevents the Progression of Established Pulmonary Hypertension Induced by Monocrotaline in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Human pulmonary endothelial cells in culture. Activities of cells from arteries and cells from veins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Long-term inhalation of nitric oxide for a patient with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Regulation of endothelin-1 synthesis in human pulmonary arterial smooth muscle cells. Effects of transforming growth factor-beta and hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Acute hypoxia alters eicosanoid production of perfused pulmonary artery endothelial cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Prostacyclin production and mediation of adenylate cyclase activity in the pulmonary artery. Alterations after prolonged hypoxia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Endothelin-A-receptor antagonist and oral prostacyclin analog are comparably effective in ameliorating pulmonary hypertension and right ventricular hypertrophy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

A role for potassium channels in smooth muscle cells and platelets in the etiology of primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Temporal alterations of endothelial-vasodilator functions in lung injury induced by monocrotaline

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Prostacyclin contributes to inhibition of hypoxic pulmonary vasoconstriction by alkalosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970290-2

7 January 2021

10.1016/S0272-5231(05)70290-2

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11590847